Skip to main content

Find Clinical Trials

Home
Conditions
Retinal Degeneration

Clinical trial condition

Retinal Degeneration

Explore clinical trials studying Retinal Degeneration. Study availability and eligibility vary by location and protocol.

1,390 public trials 173 recruiting studies

Refine in advanced search Browse all conditions

Retinal Degeneration trial results

Completed

Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD

NCT02161575

Conditions: Eye Diseases, Geographic Atrophy, Macular Degeneration, +10 more
Locations: Novartis Investigative Site Bonn, Germany

Novartis Investigative Site Karlsruhe, Germany

Novartis Investigative Site Leipzig, Germany

Novartis Investigative Site Mühlheim, Germany

View all 28 locations

View Trial Details

Completed

To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada.

NCT02540369

Conditions: Eye Diseases, Macular Degeneration, Retinal Degeneration, +2 more
Locations: Multiple Locations, Canada

View Trial Details

Completed

Brain Connectivity in Age-Related Macular Degeneration

NCT01996215

Conditions: Age-Related Macular Degeneration, Eye Diseases, Macular Degeneration, +2 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients

NCT02259088

Conditions: Diabetes Mellitus, Diabetic Macular Edema, Endocrine System Diseases, +15 more
Locations: Novartis Investigative Site Beijing, Beijing Municipality, China

Novartis Investigative Site Beijing, Beijing Municipality, China

Novartis Investigative Site Beijing, Beijing Municipality, China

Novartis Investigative Site Guangzhou, Guangdong, China

View all 28 locations

View Trial Details

Completed

Prevalence of Age Related Macular Degeneration (ARMD) in Parkinson's Patients and Assesment of the Role of L-DOPA

NCT03415984

Conditions: Age Related Macular Degeneration, Basal Ganglia Diseases, Brain Diseases, +11 more
Locations: Fondation ophtalmologique Adolphe de Rothschild Paris, France

View Trial Details

Completed

Effect Aflibercept on Ocular Perfusion

NCT03804099

Conditions: Anti Vascular Endothelial Growth Factor, Eye Diseases, Macular Degeneration, +2 more
Locations: Department of Ophthalmology, Kepler University Hospital Linz, Austria

View Trial Details

Completed

Colour Contrast Sensitivity for the Early Detection of Wet Age-related Macular Degereration (CEDAR)

NCT02173496

Conditions: Age Related Macular Degeneration, Eye Diseases, Macular Degeneration, +2 more
Locations: Aston University Birmingham, United Kingdom

View Trial Details

Completed

Variable Interval Versus Set Interval Aflibercept for DME

NCT02392364

Conditions: CYSTOID MACULAR EDEMA, Diabetic Macular Edema, Eye Diseases, +4 more
Locations: California Retina Consultants - Bakersfield Bakersfield, California, United States

California Retina Consultants - Santa Barbara Office Santa Barbara, California, United States

View Trial Details

Completed

Exercise and RP (AVAMC and Emory)

NCT03381235

Conditions: Behavior, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +8 more
Locations: Emory Clinic, Atlanta VA Medical Center Atlanta, Georgia, United States

View Trial Details

Completed

Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo

NCT03025945

Conditions: CYSTOID MACULAR EDEMA, Eye Diseases, Macular Degeneration, +3 more
Locations: Not specified

View Trial Details